What is the equity of Instem this year?
Instem has equity of 53.36 M GBP this year.
Instem Equity 2024
Instem Equity
53.36 M GBP
Ticker
INS.L
ISIN
GB00B3TQCK30
WKN
A1C7NS
In 2024, Instem's equity was 53.36 M GBP, a 12.81% increase from the 47.3 M GBP equity in the previous year.
Instem Aktienanalyse
What does Instem do?
Instem PLC is a company specialized in providing software solutions for the health and life sciences. It is headquartered in Abingdon, Oxfordshire and operates internationally. The company was founded in 2000 and has been listed on the London Stock Exchange since 2004. Instem's business model is based on helping life science companies optimize and automate their workflows. They offer a wide range of software products tailored to the specific needs of their customers. This includes systems for documenting animal experiments, clinical data collection, and solutions for regulatory drug submissions. One of Instem's key divisions is the Preclinical Solutions Division, which helps life science companies effectively plan and conduct their preclinical studies. The products in this division support the creation of study protocols, planning experimental procedures, and documenting study results. Additionally, customers of the Preclinical Solutions Division can access assistance with data collection and analysis, as well as comprehensive consulting services. Another important division of Instem is the Clinical Solutions Division, which supports clinical research facilities in conducting clinical trials. Their solutions include clinical data collection, study monitoring, and data submission to regulatory authorities. The Clinical Solutions Division also provides support for quality control and the production of statistical reports. Instem is also active in other areas, such as in vitro diagnostics and chemical approval. In these fields, the company offers a range of software solutions that aid in data collection, analysis, and reporting. A key factor that sets Instem apart from its competitors is its close collaboration with the life science community. The company works closely with customers, regulatory agencies, and interest groups to ensure that its products meet industry requirements and standards. In addition, the company has established close relationships with leading clinical and research institutions worldwide. In summary, Instem PLC is a significant provider of software solutions for the health and life sciences. The company has experienced impressive growth in recent years and strengthened its position in key market segments. Instem is well positioned to continue benefiting from the increasing demand for software solutions in the health and life sciences industry. Instem ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Instem's Equity
Instem's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Instem's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Instem's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Instem's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Instem’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Instem stock
What was the equity of Instem compared to the previous year?
The equity of Instem has increased/decreased by 12.81% increased compared to the previous year.
What impact does a high equity have on investors of Instem?
A high equity is advantageous for investors of Instem as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Instem?
A low equity can be a risk for investors of Instem, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Instem affect the company?
An increase in equity of Instem can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Instem affect the company?
A reduction in equity of Instem can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Instem?
Some factors that can affect the equity of Instem include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Instem so important for investors?
The equity of Instem is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Instem take to change the equity?
To change equity, Instem can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Instem pay?
Over the past 12 months, Instem paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Instem is expected to pay a dividend of 0 GBP.
What is the dividend yield of Instem?
The current dividend yield of Instem is .
When does Instem pay dividends?
Instem pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Instem?
Instem paid dividends every year for the past 0 years.
What is the dividend of Instem?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Instem located?
Instem is assigned to the 'Health' sector.
Wann musste ich die Aktien von Instem kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Instem from 10/15/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 10/15/2024.
When did Instem pay the last dividend?
The last dividend was paid out on 10/15/2024.
What was the dividend of Instem in the year 2023?
In the year 2023, Instem distributed 0 GBP as dividends.
In which currency does Instem pay out the dividend?
The dividends of Instem are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Instem
Our stock analysis for Instem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Instem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
